Bacterial vaginosis, Clin Microbiol, vol.4, p.3, 2015. ,
Female reproductive tract microbiome in gynecological health and problems, J Reprod Heal Med, 2016. ,
The interplay of host immunity and environment on risk of bacterial vaginosisand associated reproductive health outcomes, J Infect Dis, vol.214, issue.1, pp.29-35, 2016. ,
Lactobacillus-dominated cervicovaginal microbiota associated with reduced HIV/STI prevalence and genital HIV viral load in African women, ISME J, vol.8, issue.9, 2014. ,
Crosssectional analysis of selected genital tract immunological markers and molecular vaginal microbiota in sub-Saharan African women, with relevance to HIV risk and prevention, Clin Vaccine Immunol, vol.22, p.5, 2015. ,
The vaginal microbiota and susceptibility to HIV, AIDS, vol.28, p.16, 2014. ,
Bacterial vaginosis: a synthesis of the literature on etiology, prevalence, risk factors, and relationship with chlamydia and gonorrhea infections, Mil Med Res, vol.3, p.4, 2016. ,
Vaginal microbiome of reproductive-age women, Proc Natl Acad Sci, vol.108, issue.1, pp.4680-4687, 2011. ,
Temporal dynamics of the human vaginal microbiota, Sci Transl Med, vol.4, pp.132-52, 2012. ,
Vaginal microbiota and its role in HIV transmission and infection, FEMS Microbiol Rev, vol.37, p.5, 2013. ,
DOI : 10.1111/1574-6976.12029
URL : https://academic.oup.com/femsre/article-pdf/37/5/762/18142785/37-5-762.pdf
Origins of vaginal acidity: high D/L lactate ratio is consistent with bacteria being the primary source, Hum Reprod, vol.16, p.9, 2001. ,
Acid-dependent activities of probiotic lactobacilli against salmonella enterica serovar typhimurium pH-, lactic acid-, and non-lactic acid-dependent activities of probiotic lactobacilli against salmonella enterica serovar typhimurium Vanessa Lie, Appl Env Microbiol, vol.71, p.10, 2005. ,
Selection and identification of anaerobic lactobacilli producing inhibitory compounds against vaginal pathogens, FEMS Immunol Med Microbiol, vol.48, p.1, 2006. ,
DOI : 10.1111/j.1574-695x.2006.00124.x
URL : https://academic.oup.com/femspd/article-pdf/48/1/75/19169674/48-1-75.pdf
The restoration of the vaginal microbiota after treatment for bacterial vaginosis with metronidazole or probiotics, Microb Ecol, vol.65, p.3, 2013. ,
Inflammatory responses in the female genital tract, Immunity, vol.42, p.5, 2016. ,
Differences in the composition of vaginal microbial communities found in healthy Caucasian and black women, ISME J, vol.112, p.10, 2007. ,
Comparative meta-RNA-seq of the vaginal microbiota and differential expression by Lactobacillus iners in health and dysbiosis, Microbiome, vol.1, p.12, 2013. ,
The epidemiology of bacterial vaginosis in relation to sexual behaviour, BMC Infect Dis, vol.10, p.81, 2010. ,
Role of bacterial vaginosis in peripartum infections, Infect Dis Obstet Gynecol, vol.2, p.4, 1994. ,
Identification of novel microbes associated with pelvic inflammatory disease and infertility, Sex Transm Infect, vol.0, p.1, 2016. ,
Early pregnancy changes in bacterial vaginosis-associated bacteria and preterm delivery, Paediatr Perinat Epidemiol, vol.28, issue.2, 2014. ,
DOI : 10.1111/ppe.12106
URL : http://europepmc.org/articles/pmc4031320?pdf=render
Bacterial vaginosis assessed by gram stain and diminished colonization resistance to incident gonococcal, chlamydial, and trichomonal genital infection, J Infect Dis, vol.202, p.12, 2010. ,
Bacterial vaginosis is conducive to the persistence of HPV infection, Int J STD AIDS, vol.23, p.8, 2012. ,
Factors linked to bacterial vaginosis in nonpregnant women, Am J Public Health, vol.91, p.10, 2001. ,
The global epidemiology of bacterial vaginosis: a systematic review, Am J Obstet Gynecol, vol.209, p.6, 2013. ,
Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples, PLoS Med, vol.9, p.6, 2012. ,
In flammatory cytokine biomarkers to identify women with asymptomatic sexually transmitted infections and bacterial vaginosis who are at high risk of HIV infection, Sex Trans Infect, vol.92, pp.186-93, 2015. ,
Symptomatic vaginal discharge is a poor predictor of sexually transmitted infections and genital tract inflammation in high-risk women in South Africa, J Infect Dis, vol.206, p.1, 2012. ,
Use of lactobacillus probiotics for bacterial genitourinary infections in women: a review, Clin Ther, vol.30, p.3, 2008. ,
Effects of probiotics on the recurrence of bacterial vaginosis: a review, J Low Genit Tract Dis, vol.18, p.1, 2014. ,
Bacterial vaginosis: a review on clinical trials with probiotics, New Microbiol, vol.36, pp.229-267, 2013. ,
, Int J Food Microbiol, vol.39, p.3, 1998.
Probiotics and prebiotics-perspectives and challenges, J Sci Food Agric, vol.91, issue.8, 2011. ,
19-Probiotics. an overview of beneficial effects, Antonie Van Leeuwenhoek, vol.82, pp.279-89, 2002. ,
Effects of long-term consumption of a fermented infant formula (with Bifidobacterium breve c50 and Streptococcus thermophilus 065) on acute diarrhea in healthy infants, J Pediatr Gastroenterol Nutr, vol.39, issue.2, 2004. ,
Characterization and selection of a lactobacillus species to re-colonize the vagina of women with recurrent bacterial vaginosis, J Med Microbiol, vol.49, pp.543-52, 2000. ,
Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora, FEMS Immunol Med Microbiol, vol.32, p.1, 2001. ,
DOI : 10.1111/j.1574-695x.2001.tb00531.x
URL : https://academic.oup.com/femspd/article-pdf/32/1/37/19165471/32-1-37.pdf
Oral probiotics can resolve urogenital infections, FEMS Immunol Med Microbiol, vol.30, p.1, 2001. ,
DOI : 10.1016/s0928-8244(00)00233-9
URL : https://academic.oup.com/femspd/article-pdf/30/1/49/19165008/30-1-49.pdf
Utilization of the intestinal tract as a delivery system for urogenital probiotics, J Clin Gastroenterol, vol.38, issue.2, pp.107-117, 2004. ,
Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women, FEMS Immunol Med Microbiol, vol.35, issue.2, 2003. ,
Vaginal microbiota and the use of probiotics, Interdiscip Perspect Infect Dis, p.256490, 2008. ,
Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics, J Nutr, vol.125, p.6, 1995. ,
Prebiotics and synbiotics: towards the next generation, Curr Opin Biotechnol, vol.13, p.5, 2002. ,
DOI : 10.1016/s0958-1669(02)00365-8
Folate production by probiotic bacteria, Nutrients, vol.3, issue.1, 2011. ,
DOI : 10.3390/nu3010118
URL : https://www.mdpi.com/2072-6643/3/1/118/pdf
Vitamins and nutritional supplements, Eur. Handb. Dermatological treat, 2015. ,
DOI : 10.1007/978-3-662-45139-7_153
Genetic mechanisms of prebiotic oligosaccharide metabolism in probiotic microbes, Annu Rev Food Sci Technol, vol.6, p.1, 2015. ,
Utilization and practice of traditional/complementary/alternative medicine (TM/CAM) in South Africa, Afr J Tradit Complement Altern Med, vol.6, issue.2, 2009. ,
Bifidobacterium bifidum as an example of a specialized human gut commensal, Front Microbiol, vol.5, p.437, 2014. ,
Ecological role of lactobacilli in the gastrointestinal tract: implications for fundamental and biomedical research, Appl Environ Microbiol, vol.74, p.16, 2008. ,
Hoover-fitzula RL. Identification and inactivation of genetic loci involved with lactobacillus acidophilus acid tolerance identification and inactivation of genetic loci involved with lactobacillus acidophilus acid tolerance, Appl Environ Microbiol, vol.70, p.9, 2004. ,
Functional analysis of putative adhesion factors in lactobacillus acidophilus NCFM functional analysis of putative adhesion factors in lactobacillus acidophilus NCFM, Appl Environ Microbiol, vol.71, p.12, 2005. ,
Role of transporter proteins in bile tolerance of Lactobacillus acidophilus, Appl Environ Microbiol, vol.75, p.18, 2009. ,
Assessment of bile salt effects on S-layer production, slp gene expression, and some physicochemical properties of Lactobacillus acidophilus ATCC 4356, J Microbiol Biotechnol, vol.20, p.4, 2010. ,
The life history of lactobacillus acidophilus as a probiotic: a tale of revisionary taxonomy, misidentification and commercial success, FEMS Microbiol Lett, vol.349, issue.2, 2013. ,
The science behind the probiotic strain bifidobacterium animalis subsp, Lactis BB-12®. Microorganisms, vol.2, issue.2, 2014. ,
DOI : 10.3390/microorganisms2020092
URL : http://www.mdpi.com/2076-2607/2/2/92/pdf
Character-ML. Characterization of probiotic properties of Lactobacillus strains, Dairy Sci. Technol, vol.88, p.6, 2008. ,
, Probiotic characteristics and in vitro compatibility of a combination of Bifidobacterium breve M-16 V, Bifidobacterium longum subsp. infantis M-63 and Bifidobacterium longum subsp. longum BB536, vol.65, 2015.
Review article: Bifidobacteria as probiotic agents-Physiological effects and clinical benefits, Aliment Pharmacol Ther, vol.22, p.6, 2005. ,
Emerging role of lactobacilli in the control and maintenance of the vaginal bacterial microflora, Rev Infect Dis, vol.12, p.5, 1990. ,
Twenty-five years of research on saccharomyces boulardii trophic effects: updates and perspectives, Dig Dis Sci, vol.54, p.1, 2009. ,
Saccharomyces boulardii inhibits ERK1/2 mitogen-activated protein kinase activation both in vitro and in vivo and protects against Clostridium difficile toxin A-induced enteritis, J Biol Chem, vol.281, p.34, 2006. ,
Saccharomyces boulardii interferes with Shigella pathogenesis by postinvasion signaling events, Am J Physiol Gastrointest Liver Physiol, vol.294, p.3, 2008. ,
DOI : 10.1152/ajpgi.00391.2007
URL : http://europepmc.org/articles/pmc3212754?pdf=render
Saccharomyces boulardii ameliorates Citrobacter rodentium-induced colitis through actions on bacterial virulence factors, Am J Physiol Gastrointest Liver Physiol, vol.294, p.1, 2008. ,
DOI : 10.1152/ajpgi.00173.2007
Immunopharmacological effects of Saccharomyces boulardii in healthy human volunteers, Int J Immunopharmacol, vol.8, p.3, 1986. ,
Saccharomyces boulardii inhibits inflammatory bowel disease by trapping T cells in mesenteric lymph nodes, Gastroenterology, vol.131, p.6, 2006. ,
DOI : 10.1053/j.gastro.2006.10.001
Saccharomyces boulardii effects on gastrointestinal diseases, Curr Issues Mol Biol, vol.11, p.33, 2009. ,
Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders, Ther Adv Gastroenterol, vol.5, issue.2, 2011. ,
Endophthalmitis caused by Enterococcus mundtii, J Clin Microbiol, vol.43, p.3, 2005. ,
DOI : 10.1128/jcm.43.3.1475-1476.2005
URL : https://jcm.asm.org/content/43/3/1475.full.pdf
Genomic comparative analysis of the environmental Enterococcus mundtii against enterococcal representative species, BMC Genomics, vol.15, p.1, 2014. ,
Label claims for foods and supplements: a review of the regulations, Nutr Clin Pract, vol.20, p.1, 2005. ,
Guidance for industry on complementary and alternative medicine products and their regulation by the food and drug administration, p.17, 2006. ,
Health-benefit claims for probiotic products, Clin Infect Dis, vol.46, issue.2, pp.122-126, 2008. ,
An evaluation of nine probiotics avaliable in South Africa, SAMJ, vol.94, issue.2, 2004. ,
Evaluation of defiencies in labeling of commercial probiotics, Can Vet J, vol.44, p.12, 2003. ,